Conference Coverage
Conference Coverage
Chest pain with long COVID common but undertreated
“Our current analysis indicates that chest pain continues on for years in many individuals, suggesting that COVID-related chest pain may be...
Conference Coverage
Saltwater gargling may help avoid COVID hospitalization
Hospitalization rates in the low- (18.5%) and high- (21.4%) saline groups were significantly lower than in the reference control population.
Conference Coverage
AI tool perfect in study of inflammatory diseases
A model that combines machine learning with clinical cues could help clinicians easily differentiate MIS-C from typhus, a new study found.
Latest News
Tech encourages HIV prevention among women
“Mobile technologies, in particular, offer a nimble, customizable, and accessible way to reach this target population and increase awareness of...
Conference Coverage
AI chatbot ‘hallucinates’ faulty medical intelligence
AI models are typically a year out of date and have this “charming problem of hallucinating made-up data and saying it with all the certainty of...
Conference Coverage
Antibiotics ‘like gold’ for some, driving inappropriate use
Many felt they “knew their body, knew what they had, and knew how to treat themselves” without a health care provider.
Conference Coverage
New RSV vaccine will cut hospitalizations, study shows
With widespread use of the vaccine, annual hospitalizations resulting from infant RSV would fall by 51%, emergency department encounters would...
Conference Coverage
Wastewater can signal upswing in flu, RSV
The new study shows that wastewater-based surveillance is a “robust and adaptable” tool for community-level surveillance of seasonal respiratory...
Conference Coverage
SGLT2 inhibitors: No benefit or harm in hospitalized COVID-19
“I think the most important take-home message here is that the use of these medications appears to be safe even in really acutely ill hospitalized...
Latest News
No benefit of anti-inflammatory strategy in acute myocarditis
Interleukin-1 receptor antagonist anakinra appeared safe but did not reduce complications of acute myocarditis in the ARAMIS trial.
Conference Coverage
Rising viral load on dolutegravir? Investigators try fix before switch
“If you can get through those difficult phases, people can go back on their meds,” he said in an interview. “It’s almost a sociological problem...